Tagworks Pharmaceuticals
Marianne Uteng is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as the Managing Director at Novartis Venture Fund since May 2023. Additional leadership roles include membership on the Board of Directors at AstronauTx and Tagworks Pharmaceuticals, as well as a Board Director position at Epsilogen Ltd. and CatalYm GmbH, the latter also serving as a Board Observer. Involvement in board activities extends to Amphista Therapeutics Limited and Rappta Therapeutics. Marianne Uteng holds a PhD in Cell Biology & Biophysics from the European Molecular Biology Laboratory and a Master's degree in Biochemistry from the University of Oslo.
This person is not in any teams
This person is not in any offices
Tagworks Pharmaceuticals
1 followers
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands. Tagworks develops In vivo chemistry to improve the efficacy of cancer therapies and to enable novel approaches in companion diagnostics. The company’s facilities are located at the Radboud University Medical Center in Nijmegen. Founded in 2011, Tagworks is aspin-out of Philips Healthcare, and originates from Philips’ molecular imaging expertise.